Review article: tegaserod: the global experienceCHEY, W. D.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 7, pp 15-19, issn 0953-0673, 5 p.Article

New insights into the human 5-HT₄ receptor binding site: exploration of a hydrophobic pocketRIVAIL, Lucie; GINER, Mireille; GASTINEAU, Monique et al.British journal of pharmacology. 2004, Vol 143, Num 3, pp 361-370, issn 0007-1188, 10 p.Article

Assignment^a of 5-hydroxytryptamine receptor (htr4) to human chromosome 5 bands q31 → q33 by in situ hybridizationCLAEYSEN, S; FAYE, P; SEBBEN, M et al.Cytogenetics and cell genetics. 1997, Vol 78, Num 2, pp 133-134, issn 0301-0171Article

Metabolism and Pharmacokinetics of Naronapride (ATI-7505), a Serotonin 5-HT₄ Receptor Agonist for Gastrointestinal Motility DisordersBOWERSOX, S. Scott; LIGHTNING, Luke K; RAO, Satish et al.Drug metabolism and disposition. 2011, Vol 39, Num 7, pp 1170-1180, issn 0090-9556, 11 p.Article

Do 5-HT₄ receptors mediate the intestinal secretory response to 5-HT in rat in-vivo ?FRANKS, C. M; HARDCASTLE, J; HARDCASTLE, P. T et al.Journal of pharmacy and pharmacology. 1995, Vol 47, Num 3, pp 213-218, issn 0022-3573Article

Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia : Results of two Randomized Controlled TrialsVAKIL, Nimish; LAINE, Loren; TALLEY, Nicholas J et al.The American journal of gastroenterology. 2008, Vol 103, Num 8, pp 1906-1919, issn 0002-9270, 14 p.Article

Differences in responses to 5-HT₄ receptor agonists and antagonists of the 5-HT₄-like receptor in human colon circular smooth muscleTAM, F. S.-F; HILLIER, K; BUNCE, K. T et al.British journal of pharmacology. 1995, Vol 115, Num 1, pp 172-176, issn 0007-1188Article

Modulation of intestinal gas dynamics in healthy human volunteers by the 5-HT₄ receptor agonist tegaserodCOLESKI, Radoslav; OWYANG, Chung; HASLER, William L et al.The American journal of gastroenterology. 2006, Vol 101, Num 8, pp 1858-1865, issn 0002-9270, 8 p.Article

Perspectives physiopathologiques et thérapeutiques des nouveaux récepteurs sérotoninergiques : à propos du récepteur de type 4 = Pathophysiology and therapeutic applications of serotonin 5-HT4 receptor subtypeLEFEBVRE, H.La Revue de médecine interne (Paris). 2000, Vol 21, Num 8, pp 661-663, issn 0248-8663Article

Electrophysiological Characterization of Isolated Human Atrial Myocytes Exposed to TegaserodSUFFREDINI, Silvia; CERBAI, Elisabetta; GIUNTI, Gabriele et al.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 5, pp 416-421, issn 1742-7835, 6 p.Article

Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteersZOU, Jian-Jun; BIAN, Xiao-Jie; LI DING et al.Journal of chromatography. B. 2008, Vol 861, Num 1, pp 151-157, issn 1570-0232, 7 p.Article

Tegaserod for constipation-predominant irritable bowel syndromeKALE-PRADHAN, Pramodini B; WILHELM, Sheila M.Pharmacotherapy. 2007, Vol 27, Num 2, pp 267-277, issn 0277-0008, 11 p.Article

Effects of a 5-HT₄ receptor agonist on oesophageal function and gastro-oesophageal reflux : Studies using combined impedance-manometry and combined impedance-pHTUTUIAN, R; MAINIE, I; ALLAN, R et al.Alimentary pharmacology & therapeutics. 2006, Vol 24, Num 1, pp 155-162, issn 0269-2813, 8 p.Article

The effects of the specific 5HT₄ receptor agonist, prucalopride, on colonic motility in healthy volunteersDE SCHRYVER, A. M. P; ANDRIESSE, G. I; SAMSOM, M et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 603-612, issn 0269-2813Article

Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndromeTOUGAS, G; SNAPE, W. J; OTTEN, M. H et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 10, pp 1701-1708, issn 0269-2813, 8 p.Article

5-HT inhibits spontaneous contractility of isolated sheep mesenteric lymphatics via activation of 5-HT₄ receptorsMCHALE, N. G; THORNBURY, K. D; HOLLYWOOD, M. A et al.Microvascular research (Print). 2000, Vol 60, Num 3, pp 261-268, issn 0026-2862Article

Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteersPOEN, A. C; FELT-BERSMA, R. J. F; VAN DONGEN, P. A. M et al.Alimentary pharmacology & therapeutics. 1999, Vol 13, Num 11, pp 1493-1497, issn 0269-2813Article

5-HT₄ receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis studyTHORRE, K; EBINGER, G; MICHOTTE, Y et al.Brain research. 1998, Vol 796, Num 1-2, pp 117-124, issn 0006-8993Article

Cloning, expression, and pharmacology of four human 5-Hydroxytryptamine₄ receptor isoforms produced by alternative splicing in the carboxyl terminusBLONDEL, O; GASTINEAU, M; DAHMOUNE, Y et al.Journal of neurochemistry. 1998, Vol 70, Num 6, pp 2252-2261, issn 0022-3042Article

Evidence for the involvement of 5-HT₄ receptors in the 5-hydroxytryptamine-induced pattern of migrating myoelectric complex in sheepPLAZA, M.-A; ARRUEBO, M.-P; MURILLO, M.-D et al.British journal of pharmacology. 1997, Vol 120, Num 6, pp 1144-1150, issn 0007-1188Article

Antagonism by SB 204070 of 5-HT-evoked contractions in the dog stomach : an in-vivo model of 5-HT₄ receptor functionBINGHAM, S; KING, B. F; RUSHANT, B et al.Journal of pharmacy and pharmacology. 1995, Vol 47, Num 3, pp 219-222, issn 0022-3573Article

Prucalopride: A Review of Its Use in the Management of Chronic ConstipationKEATING, Gillian M.Drugs (Basel). 2013, Vol 73, Num 17, pp 1935-1950, issn 0012-6667, 16 p.Article

SECONDARY MECHANICAL ALLODYNIA AND HYPERALGESIA DEPEND ON DESCENDING FACILITATION MEDIATED BY SPINAL 5-HT₄, 5-HT₆ AND 5-HT₇ RECEPTORSGODINEZ-CHAPARRO, B; LOPEZ-SANTILLAN, F. J; ORDUNA, P et al.Neuroscience. 2012, Vol 222, pp 379-391, issn 0306-4522, 13 p.Article

Effects of the 5-HT₄ receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levelsLICHT, Cecilie Löe; KNUDSEN, Gitte Moos; SHARP, Trevor et al.Neuroscience letters. 2010, Vol 476, Num 2, pp 58-61, issn 0304-3940, 4 p.Article

Conformational state of human cardiac 5-HT_4(g) receptors influences the functional effects of polyclonal anti-5-HT₄ receptor antibodiesDI SCALA, Emmanuella; ROSE, Stéphanie; HERAULT, Olivier et al.Biochemical pharmacology. 2007, Vol 73, Num 7, pp 964-971, issn 0006-2952, 8 p.Article